Urology Health - Lo que debe saber acera del nmCRPC, cáncer de próstata resistente a la castración no metastásico

Advertisement

Centro de recursos Patient Magazine Podcast Donate

Lo que debe saber acera del nmCRPC, cáncer de próstata resistente a la castración no metastásico

Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Lo que debe saber acera del nmCRPC, cáncer de próstata resistente a la castración no metastásico

Lo que debe saber acera del nmCRPC, cáncer de próstata resistente a la castración no metastásico

Resumen de lo que los pacientes deben saber sobre nmCRPC, cáncer de próstata resistente a la castración no metastásico (nmCRPC What You Should Know)

Español translation courtesy of Confederacion Americana de Urologia (CAU)